Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.804 SEK | -4.74% | -12.21% | +16.84% |
May. 06 | Transcript : Alligator Bioscience AB, Q1 2024 Earnings Call, May 06, 2024 | |
May. 06 | Alligator Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 58
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibody-based Medicines
100.0
%
| 36 | 100.0 % | 58 | 100.0 % | +62.78% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Finland
100.0
%
| 36 | 100.0 % | 58 | 100.0 % | +62.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 53 | 21-05-31 |
Marie Svensson
DFI | Director of Finance/CFO | 60 | 20-08-31 |
Chief Tech/Sci/R&D Officer | 56 | 22-01-31 | |
Peter Ellmark
CTO | Chief Tech/Sci/R&D Officer | 51 | 17-12-31 |
Chief Tech/Sci/R&D Officer | 42 | 13-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 70 | 16-12-31 | |
Staffan Encrantz
BRD | Director/Board Member | 73 | 22-05-08 |
Director/Board Member | 62 | 21-05-31 | |
Denise Goode
BRD | Director/Board Member | 66 | 22-05-08 |
Director/Board Member | 53 | 21-05-31 | |
Chief Tech/Sci/R&D Officer | 42 | 13-12-31 | |
62 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 949,850 | 0 | 0 | 59.28 % |
Stock B | 1 | 657,954,290 | 390,619,939 ( 59.37 %) | 0 |
Company contact information
Alligator Bioscience AB
Medicon Village Scheelevägen 2
223 81, Lund
+46 4 65 40 82 00
http://www.alligatorbioscience.comGroup companies
Name | Category and Sector |
---|---|
A Bioscience Incentive AB
|
Sector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.84% | 58.88M | |
+23.37% | 47.02B | |
+49.90% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- ATORX Stock
- Company Alligator Bioscience AB